Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-κB. (Q39566599)

13 September 2017

title

Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-κB. (English)

1 reference

13 September 2017

0 references

0 references

1 reference

Mi Hee Park

1

1 reference

13 September 2017

Myoung Suk Choi

2

1 reference

13 September 2017

Dong Hoon Kwak

3

1 reference

13 September 2017

Ki-Wan Oh

4

1 reference

13 September 2017

Do Young Yoon

5

1 reference

13 September 2017

Sang Bae Han

6

1 reference

13 September 2017

Ho Sueb Song

7

1 reference

13 September 2017

Min Jong Song

8

1 reference

13 September 2017

Jin Tae Hong

9

1 reference

13 September 2017

publication date

17 November 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

71

1 reference

13 September 2017

issue

8

1 reference

13 September 2017

page(s)

801-812

1 reference

Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Early chemotherapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Combination hormonal therapy: a reassessment within advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Hormone therapy and radiotherapy for intermediate risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Secondary hormonal therapy for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

New therapeutic targets in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Outcome of patients with hormone-refractory prostate cancer: prognostic significance of prostate-specific antigen-doubling time and nadir prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Prostate cancer chemotherapy in the era of targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Dietary supplementation with silymarin inhibits 3,2'-dimethyl-4-aminobiphenyl-induced prostate carcinogenesis in male F344 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Soy isoflavone genistein in prevention and treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

NF-kappaB: linking inflammation and immunity to cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Inhibition of IkappaB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Chemotherapy-induced CXC-chemokine/CXC-chemokine receptor signaling in metastatic prostate cancer cells confers resistance to oxaliplatin through potentiation of nuclear factor-kappaB transcription and evasion of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

N-acetyl-L-cysteine enhances chemotherapeutic effect on prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Drug resistance in cancer: principles of emergence and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Honeybee venom: a rich source of pharmacologically active peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Melittin inhibits vascular smooth muscle cell proliferation through induction of apoptosis via suppression of nuclear factor-kappaB and Akt activation and enhancement of apoptotic protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Bee venom induces apoptosis and inhibits expression of cyclooxygenase-2 mRNA in human lung cancer cell line NCI-H1299.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1-JNK/p38 and inhibiting IkappaBalpha kinase-NFkap

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Control of apoptosis by Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastro-intestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Inhibitory effect of snake venom toxin from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: induction of apoptosis through inactivation of nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

Nuclear Factor- B Nuclear Localization Is Predictive of Biochemical Recurrence in Patients with Positive Margin Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21296

21 January 2018

Identifiers

DOI

10.1002/PROS.21296

1 reference

13 September 2017

1 reference